Led KOL engagement and facilitated high-level scientific discussions on vedolizumab (IBD therapy) in top-tier hospitals, strengthening clinical adoption and visibility of the therapy. Organized and chaired a China–US real-world research collaboration meeting, involving three top national IBD centers and US academic partners, enhancing international scientific exchange. Led the regional implementation of the IBDQCC project, overseeing hospital selection and evaluation within my territory at China’s leading national IBD center. Coordinated the Takeda-sponsored session in the 9th Annual Meeting of the Asian Organization for Crohn's and Colitis (AOCC2021) in China, liaising between Takeda China and Global Medical HQ to finalize scientific presentations and arrange chairperson schedules, contributing to the conference's success with over 1,000 international participants. Initiated and led a regional clinical education program, training 70 physicians on IBD patient management and improving clinical practice in the region.

Established a medical terminology standardization platform.